Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38351-38400 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06345235
New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis
N/ARecruiting
100 participants
Started: Jul 11, 2023 · Completed: Jul 11, 2024
1 condition1 sponsor1 location
NCT05950438
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
N/ARecruiting
25 participants
Started: Jul 11, 2023 · Completed: May 25, 2028
1 condition1 sponsor1 location
NCT07133958
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
N/ARecruiting
35 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05774314
The Impact of Community Health Workers on Child Malnutrition in the Philippines
NARecruiting
7,650 participants
Started: Jul 11, 2023 · Completed: May 31, 2025
1 condition3 sponsors4 locations
NCT05961865
Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation
N/ARecruiting
180 participants
Started: Jul 11, 2023 · Completed: Aug 31, 2027
4 conditions2 sponsors1 location
NCT05847270
Surgical Treatment of Irreducible Atlantoaxial Dislocation
NARecruiting
70 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
1 condition6 sponsors1 location
NCT05838274
Acute Alcohol Response in Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
NARecruiting
100 participants
Started: Jul 11, 2023 · Completed: Mar 31, 2028
3 conditions1 sponsor1 location
NCT05703269
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
NARecruiting
244 participants
Started: Jul 11, 2023 · Completed: Mar 31, 2028
8 conditions2 sponsors39 locations
NCT05795439
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
NARecruiting
700 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05952440
Dissecting the Cellular and Molecular Atlas of Rheumatoid Arthritis in Sustained Remission to Identify Pathways Maintaining Remission and Triggering Flares
N/ARecruiting
130 participants
Started: Jul 11, 2023 · Completed: May 10, 2026
1 condition4 sponsors4 locations
NCT05546996
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
NARecruiting
24 participants
Started: Jul 11, 2023 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT05790486
Take A Break - Rural
NARecruiting
800 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
3 conditions3 sponsors1 location
NCT05948839
pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression
NARecruiting
170 participants
Started: Jul 11, 2023 · Completed: Sep 1, 2024
2 conditions5 sponsors3 locations
NCT06108193
Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris
PHASE1/PHASE2Recruiting
26 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT06111001
NHS Staff Digital Wellbeing Via AirEmail
NARecruiting
172 participants
Started: Jul 11, 2023 · Completed: Dec 11, 2023
5 conditions1 sponsor1 location
NCT05342064
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
NARecruiting
6,500 participants
Started: Jul 11, 2023 · Completed: Sep 30, 2026
3 conditions5 sponsors5 locations
NCT05818462
Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors
N/ARecruiting
60 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05911217
A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer
PHASE1Recruiting
20 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors8 locations
NCT05924477
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
NARecruiting
226 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2027
1 condition4 sponsors8 locations
NCT05677451
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up
PHASE3Recruiting
100 participants
Started: Jul 11, 2023 · Completed: Mar 30, 2032
1 condition1 sponsor63 locations
NCT06005493
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
280 participants
Started: Jul 11, 2023 · Completed: Jun 15, 2027
4 conditions1 sponsor25 locations
NCT05953467
Healthcare Seeking Behavior of Frequent Emergency Care Visitors
N/ARecruiting
700 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05928416
ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach
N/ARecruiting
600 participants
Started: Jul 11, 2023 · Completed: Jul 31, 2025
2 conditions2 sponsors19 locations
NCT05867381
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
NARecruiting
112 participants
Started: Jul 11, 2023 · Completed: Jun 30, 2027
2 conditions3 sponsors1 location
NCT06202898
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
NARecruiting
110 participants
Started: Jul 11, 2023 · Completed: Jun 30, 2027
3 conditions5 sponsors1 location
NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT and KarXT + KarX-EC in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
PHASE3Recruiting
800 participants
Started: Jul 11, 2023 · Completed: Sep 7, 2027
1 condition1 sponsor392 locations
NCT05433129
Non-Invasive Mapping of Cerebral Autoregulation Using Near Infrared Spectroscopy
NARecruiting
250 participants
Started: Jul 11, 2023 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05801939
Cevostamab Following CAR T Cell Therapy for RRMM
PHASE2Recruiting
30 participants
Started: Jul 11, 2023 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT05851443
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
PHASE2Recruiting
240 participants
Started: Jul 11, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor84 locations
NCT05710848
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
PHASE1/PHASE2Recruiting
75 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations
NCT05870982
Early vs. Late Time Restricted Eating vs. Daily Caloric Restriction
NARecruiting
162 participants
Started: Jul 11, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT05926687
Optimizing Outcomes for Young Autistic Children
PHASE2Recruiting
184 participants
Started: Jul 11, 2023 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT06256627
"The Maintenance Treatment of ITIVA in AML Patients"
NARecruiting
130 participants
Started: Jul 11, 2023 · Completed: May 1, 2027
8 conditions1 sponsor1 location
NCT05912413
Predicton of Sepsis Recovery Performance Subtypes Pilot Study
N/ARecruiting
40 participants
Started: Jul 11, 2023 · Completed: Oct 15, 2025
1 condition1 sponsor1 location
NCT06380218
Evaluation of Nutritional Prevention Program for Women's Cardiovascular Health on Quality of Life (SAFE)
NARecruiting
50 participants
Started: Jul 11, 2023 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT05941728
Persea Americana for Total Health (PATH)-2
NARecruiting
45 participants
Started: Jul 11, 2023 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT05638204
Effectiveness of the Suicidal Crisis Intervention (SCI)
NARecruiting
390 participants
Started: Jul 11, 2023 · Completed: Jan 1, 2026
3 conditions1 sponsor12 locations
NCT05909618
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
PHASE2Recruiting
33 participants
Started: Jul 11, 2023 · Completed: Jul 30, 2030
3 conditions2 sponsors1 location
NCT05792930
Developing an Integrated Psychotherapy With Cognitive-behavioral Therapy and Biofeedback Therapy for Somatic Symptom Disorder
NARecruiting
60 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05896020
A Study of SHR-A1811 in Subjects With Gynaecologic Oncology
PHASE2Recruiting
225 participants
Started: Jul 10, 2023 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT05838287
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
PHASE4Recruiting
78 participants
Started: Jul 10, 2023 · Completed: Jan 31, 2030
2 conditions1 sponsor1 location
NCT05981066
A Clinical Study of mRNA Vaccine (ABOR2014/IPM511) in Patients With Advanced Hepatocellular Carcinoma
NARecruiting
48 participants
Started: Jul 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06149962
Comparison Between Functional Outcomes of Flexor Tendon Repair Under WALANT and Brachial Plexus Block
NARecruiting
30 participants
Started: Jul 10, 2023 · Completed: Jul 10, 2024
1 condition1 sponsor1 location
NCT05941780
Pain Phenotypes in Patients with Fibromyalgia Syndrome
N/ARecruiting
60 participants
Started: Jul 10, 2023 · Completed: Jan 30, 2025
6 conditions1 sponsor1 location
NCT05858060
Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage
N/ARecruiting
124 participants
Started: Jul 10, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05552755
Evaluate REC-4881 in Patients With FAP
PHASE1/PHASE2Recruiting
67 participants
Started: Jul 10, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor17 locations
NCT05734625
Efficacy of Nerve Blocks for Episodic Migraine
PHASE2Recruiting
60 participants
Started: Jul 10, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05753761
The Whole Day Matters After Stroke (BIG-STEPS)
NARecruiting
50 participants
Started: Jul 10, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05998512
Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)
N/ARecruiting
1,000 participants
Started: Jul 10, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations
NCT05876676
RDC Biomarker Study
N/ARecruiting
1,000 participants
Started: Jul 10, 2023 · Completed: Jul 10, 2032
1 condition1 sponsor10 locations